1. Home
  2. NHC vs AMLX Comparison

NHC vs AMLX Comparison

Compare NHC & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National HealthCare Corporation

NHC

National HealthCare Corporation

HOLD

Current Price

$161.44

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

HOLD

Current Price

$13.99

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NHC
AMLX
Founded
1971
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
1.3B
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
NHC
AMLX
Price
$161.44
$13.99
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$19.56
AVG Volume (30 Days)
64.4K
820.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.64%
N/A
EPS Growth
17.46
65.46
EPS
7.67
N/A
Revenue
$1,517,781,000.00
$380,786,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$20.34
N/A
Revenue Growth
16.09
1612.94
52 Week Low
$89.14
$3.11
52 Week High
$174.54
$17.49

Technical Indicators

Market Signals
Indicator
NHC
AMLX
Relative Strength Index (RSI) 52.55 46.19
Support Level $153.93 $13.28
Resistance Level $173.09 $15.41
Average True Range (ATR) 6.13 0.99
MACD -1.68 -0.07
Stochastic Oscillator 40.06 16.14

Price Performance

Historical Comparison
NHC
AMLX

About NHC National HealthCare Corporation

National Healthcare Corp provides long-term care facilities. Its principal business includes operating skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services and Home care and hospice services. The majority of revenue is derived from the Inpatient services segment.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

Share on Social Networks: